Fallopian Tube Cancer
📧 Sign up to get email alerts when something new happens for Fallopian Tube Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-06-26Clinical Trial Update: An Interventional Study of Avastin (Bevacizumab) in Patients With Advanced/Metastatic Epithelial Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer [Phase 4]
A Phase 4 interventional trial evaluating Avastin (bevacizumab) in advanced or metastatic ovarian, fallopian tube, or primary peritoneal can…
-
CLINICAL_TRIALS trial_result · 2025-06-24Clinical Trial Update: A Study in Ovarian Cancer Patients Evaluating Rucaparib and Nivolumab as Maintenance Treatment Following Response to Front-Line Platinum-Based Chemotherapy [Phase 3]
A Phase 3 trial update reports results for maintenance therapy with rucaparib and nivolumab in ovarian cancer patients who responded to fron…
-
CLINICAL_TRIALS trial_result · 2025-06-11Clinical Trial Update: AVB-S6-500 and Durvalumab in Treating Patients With Platinum-Resistant or Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer [Phase 1, Phase 2]
This document reports the termination of a Phase 1/2 trial of AVB-S6-500 in combination with durvalumab for platinum-resistant or recurrent …
-
CLINICAL_TRIALS trial_result · 2025-06-11Clinical Trial Update: European Trial on Enhanced DNA Repair Inhibition in Ovarian Cancer [Phase 2]
Phase 2 European trial evaluating enhanced DNA repair inhibition in ovarian cancer has completed enrollment and posted results. The study al…
-
CLINICAL_TRIALS trial_result · 2025-06-08Clinical Trial Update: A Study to Evaluate the Safety of KAND567, in Combination With Carboplatin Therapy, in Women With Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer [Phase 1, Phase 2]
This clinical trial update reports the completion of a Phase 1/2 study evaluating the safety of KAND567 in combination with carboplatin in w…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-06-04Clinical Trial Update: Phase IB Study to Evaluate the Safety of Selinexor (KPT-330) in Combination With Multiple Standard Chemotherapy or Immunotherapy Agents in Patients With Advanced Malignancies [Phase 1]
A Phase Ib safety study of Selinexor (KPT-330) in combination with standard chemotherapy or immunotherapy agents for patients with advanced …
-
CLINICAL_TRIALS trial_result · 2025-05-23Clinical Trial Update: A Study of NM21-1480 in Adult Patients With Advanced Solid Tumors [Phase 1, Phase 2]
A clinical trial update reports termination of the NM21-1480 study in adults with advanced solid tumors, including non-small cell lung cance…
-
CLINICAL_TRIALS trial_result · 2025-05-22Clinical Trial Update: Nivolumab With or Without Ipilimumab in Treating Patients With Recurrent or High Grade Gynecologic Cancer With Metastatic Peritoneal Carcinomatosis [Phase 1]
Phase 1 study evaluating nivolumab with or without ipilimumab in patients with recurrent or high-grade gynecologic cancers and metastatic pe…
-
CLINICAL_TRIALS trial_result · 2025-05-22Clinical Trial Update: Evaluation of GTPase Inhibition by Post-operative Intravenous Ketorolac in Ovarian Cancer Patients [NA]
A completed clinical trial evaluated post-operative intravenous ketorolac for GTPase inhibition in ovarian cancer patients. The study also i…
-
CLINICAL_TRIALS trial_result · 2025-05-06Clinical Trial Update: Testing the Combination of Cediranib and Olaparib in Comparison to Each Drug Alone or Other Chemotherapy in Recurrent Platinum-Resistant Ovarian Cancer [Phase 2, Phase 3]
Results from a Phase 2/3 trial evaluating the combination of cediranib and olaparib versus each drug alone or chemotherapy in recurrent plat…
-
CLINICAL_TRIALS trial_result · 2025-05-06Clinical Trial Update: Testing the Combination of Cediranib and Olaparib in Comparison to Each Drug Alone or Other Chemotherapy in Recurrent Platinum-Resistant Ovarian Cancer [Phase 2, Phase 3]
Phase 2/3 trial updating the combination of cediranib and olaparib versus each drug alone or other chemotherapy in recurrent platinum-resist…
-
CLINICAL_TRIALS trial_result · 2025-04-30Clinical Trial Update: Study of Relacorilant in Combination With Nab-Paclitaxel for Patients With Recurrent Platinum-Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer [Phase 2]
Phase 2 trial of relacorilant with nab-paclitaxel in recurrent platinum-resistant ovarian, fallopian tube, or primary peritoneal cancer has …
-
CLINICAL_TRIALS trial_result · 2025-04-29Clinical Trial Update: CAR T Cells in Mesothelin Expressing Cancers [Phase 1]
Phase 1 study evaluating mesothelin-targeted CAR T cells in mesothelin-expressing cancers; results have been posted for a University of Penn…
-
CLINICAL_TRIALS trial_result · 2025-04-23Clinical Trial Update: Geriatric Assessment and Nursing Telephone Intervention in Elderly Women With Ovarian Cancer
This update notes the completion of a clinical trial evaluating geriatric assessment plus nursing telephone support for elderly women with o…
-
CLINICAL_TRIALS trial_result · 2025-04-13Clinical Trial Update: Study of IBI354 Versus Investigator's Choice of Chemotherapy in Patients With Platinum-resistant Ovarian, Primary Peritoneal, or Fallopian Tube Cancer [Phase 3]
Phase 3 study comparing IBI354 to investigator's choice chemotherapy in platinum-resistant ovarian, primary peritoneal, or fallopian tube ca…
-
CLINICAL_TRIALS trial_result · 2025-03-26Clinical Trial Update: MOv19-BBz CAR T Cells in aFR Expressing Recurrent High Grade Serous Ovarian, Fallopian Tube, or Primary Peritoneal Cancer [Phase 1]
Phase 1 trial update of MOv19-BBz CAR T cells targeting aFR-expressing recurrent high-grade serous ovarian, fallopian tube, or primary perit…
-
CLINICAL_TRIALS trial_result · 2025-03-13Clinical Trial Update: Atezolizumab, Guadecitabine, and CDX-1401 Vaccine in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer [Phase 1, Phase 2]
Clinical trial update of atezolizumab, guadecitabine, and CDX-1401 vaccine in recurrent platinum-resistant ovarian, fallopian tube, and prim…
-
CLINICAL_TRIALS trial_result · 2025-03-07Clinical Trial Update: BP1001-A in Patients With Advanced or Recurrent Solid Tumors [Phase 1]
This clinical trial update states that BP1001-A is being evaluated in a Phase 1 study for advanced or recurrent solid tumors and is currentl…
-
CLINICAL_TRIALS trial_result · 2025-03-04Clinical Trial Update: Pegylated Liposomal Doxorubicin Hydrochloride With Atezolizumab and/or Bevacizumab in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer [Phase 2, Phase 3]
This clinical trial update reports results from a Phase 2/3 study evaluating pegylated liposomal doxorubicin in combination with atezolizuma…
-
CLINICAL_TRIALS trial_result · 2025-02-21Clinical Trial Update: Study of Intraperitoneal Carboplatin With IV Paclitaxel and Bevacizumab in Untreated Ovarian Cancer [Phase 1]
Phase 1 study evaluating intraperitoneal carboplatin with intravenous paclitaxel and bevacizumab in untreated ovarian cancer has completed.
-
CLINICAL_TRIALS trial_result · 2025-02-20Clinical Trial Update: Heated Intra-peritoneal Chemotherapy With Doxorubicin and Cisplatin for Abdominal for Pelvic Tumors in Pediatric Patients [EARLY_Phase 1]
Early-phase 1 clinical trial evaluating heated intraperitoneal chemotherapy with doxorubicin and cisplatin for pediatric abdominal/pelvic tu…
-
CLINICAL_TRIALS trial_result · 2025-02-20Clinical Trial Update: PARPi and Ovarian Cancer Survival
A not-yet-recruiting clinical trial is investigating a PARP inhibitor for epithelial ovarian cancer and related cancers of the fallopian tub…
-
CLINICAL_TRIALS trial_result · 2025-02-13Clinical Trial Update: Mirvetuximab Soravtansine and Rucaparib Camsylate in Treating Participants With Recurrent Endometrial, Ovarian, Fallopian Tube or Primary Peritoneal Cancer [Phase 1]
A Phase 1 trial evaluates the combination of mirvetuximab soravtansine and rucaparib camsylate in patients with recurrent gynecologic cancer…
-
CLINICAL_TRIALS trial_result · 2025-01-30Clinical Trial Update: Phase 1 Study of SL-172154 (SIRPα-Fc-CD40L) in Subjects With Ovarian Cancer [Phase 1]
Phase 1 study of SL-172154 (SIRPα-Fc-CD40L) in ovarian, fallopian tube, and primary peritoneal cancers has completed enrollment and posted r…
-
CLINICAL_TRIALS trial_result · 2025-01-17Clinical Trial Update: Newton Study (NEW Dosing MainTenance Therapy Ovarian CaNcer) [Phase 2]
A Phase 2 trial called Newton (NEW Dosing Maintenance Therapy Ovarian Cancer) sponsored by the Mario Negri Institute has been terminated. Th…